Global Treatment Resistant Hypertension Management Industry

2023-2029 Global Treatment-Resistant Hypertension Management Industry Research & Trends Analysis Report

Global Treatment Resistant Hypertension Management Industry

2023-2029 Global Treatment-Resistant Hypertension Management Industry Research & Trends Analysis Report


Treatment-Resistant Hypertension Management Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.


Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to Latest Study , the global market for Treatment-Resistant Hypertension Management should grow from US$ 58 million in 2023 to US$ 184.7 million by 2030, with a CAGR of 17.0% for the period of 2024-2030.

China Treatment-Resistant Hypertension Management market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Treatment-Resistant Hypertension Management market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Diuretic Therapy segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Hospital Pharmacy has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.

The global key manufacturers of Treatment-Resistant Hypertension Management include Janssen Biotech, Quantum Genomics, CinCor Pharma, Ionis Pharmaceuticals, Vifor Pharma, KBP Biosciences, Abbott, Kona Medical and Medtronic, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

The management of Treatment-Resistant Hypertension typically involves the use of multiple classes of antihypertensive medications, such as diuretics, beta-blockers, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor blockers (ARBs).

This report aims to provide a comprehensive study of the global market for Treatment-Resistant Hypertension Management. Report Highlights:

(1) Global Treatment-Resistant Hypertension Management market size (value), history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Treatment-Resistant Hypertension Management market competitive situation, revenue and market share, from 2019 to 2024.

(3) China Treatment-Resistant Hypertension Management market competitive situation, revenue and market share, from 2019 to 2024.

(4) Global Treatment-Resistant Hypertension Management segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Treatment-Resistant Hypertension Management segment by type and by application and regional segment by type and by application.

(6) Treatment-Resistant Hypertension Management industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Diuretic Therapy

Combination Therapy

Mineralocorticoid Receptor Antagonists

Market segment by application, can be divided into

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Market segment by players, this report covers

Janssen Biotech

Quantum Genomics

CinCor Pharma

Ionis Pharmaceuticals

Vifor Pharma

KBP Biosciences

Abbott

Kona Medical

Medtronic

1 Market Overview

1.1 Product Overview and Scope of Treatment-Resistant Hypertension Management

1.2 Global Treatment-Resistant Hypertension Management Market Size and Forecast

1.3 China Treatment-Resistant Hypertension Management Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Treatment-Resistant Hypertension Management Share in Global Market, 2019-2030

1.4.2 Treatment-Resistant Hypertension Management Market Size: China VS Global, 2019-2030

1.5 Treatment-Resistant Hypertension Management Market Dynamics

1.5.1 Treatment-Resistant Hypertension Management Market Drivers

1.5.2 Treatment-Resistant Hypertension Management Market Restraints

1.5.3 Treatment-Resistant Hypertension Management Industry Trends

1.5.4 Treatment-Resistant Hypertension Management Industry Policy

2 Global Competitive Situation by Company

2.1 Global Treatment-Resistant Hypertension Management Revenue by Company (2019-2024)

2.2 Global Treatment-Resistant Hypertension Management Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Treatment-Resistant Hypertension Management Concentration Ratio

2.4 Global Treatment-Resistant Hypertension Management Mergers & Acquisitions, Expansion Plans

2.5 Global Treatment-Resistant Hypertension Management Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Treatment-Resistant Hypertension Management Revenue by Company (2019-2024)

3.2 China Treatment-Resistant Hypertension Management Treatment-Resistant Hypertension Management Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Treatment-Resistant Hypertension Management, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)

4 Industry Chain Analysis

4.1 Treatment-Resistant Hypertension Management Industry Chain

4.2 Treatment-Resistant Hypertension Management Upstream Analysis

4.3 Treatment-Resistant Hypertension Management Midstream Analysis

4.4 Treatment-Resistant Hypertension Management Downstream Analysis

5 Sights by Type

5.1 Treatment-Resistant Hypertension Management Classification

5.1.1 Diuretic Therapy

5.1.2 Combination Therapy

5.1.3 Mineralocorticoid Receptor Antagonists

5.2 By Type, Global Treatment-Resistant Hypertension Management Market Size & CAGR, 2019 VS 2023 VS 2030

5.3 By Type, Global Treatment-Resistant Hypertension Management Revenue, 2019-2030

6 Sights by Application

6.1 Treatment-Resistant Hypertension Management Segment by Application

6.1.1 Hospital Pharmacy

6.1.2 Online Pharmacy

6.1.3 Retail Pharmacy

6.2 By Application, Global Treatment-Resistant Hypertension Management Market Size & CAGR, 2019 VS 2023 VS 2030

6.3 By Application, Global Treatment-Resistant Hypertension Management Revenue, 2019-2030

7 Sales Sights by Region

7.1 By Region, Global Treatment-Resistant Hypertension Management Market Size, 2019 VS 2023 VS 2030

7.2 By Region, Global Treatment-Resistant Hypertension Management Market Size, 2019-2030

7.3 North America

7.3.1 North America Treatment-Resistant Hypertension Management Market Size & Forecasts, 2019-2030

7.3.2 By Country, North America Treatment-Resistant Hypertension Management Market Size Market Share

7.4 Europe

7.4.1 Europe Treatment-Resistant Hypertension Management Market Size & Forecasts, 2019-2030

7.4.2 By Country, Europe Treatment-Resistant Hypertension Management Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Treatment-Resistant Hypertension Management Market Size & Forecasts, 2019-2030

7.5.2 By Country/Region, Asia Pacific Treatment-Resistant Hypertension Management Market Size Market Share

7.6 South America

7.6.1 South America Treatment-Resistant Hypertension Management Market Size & Forecasts, 2019-2030

7.6.2 By Country, South America Treatment-Resistant Hypertension Management Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Treatment-Resistant Hypertension Management Market Size & CAGR，2019 VS 2023 VS 2030

8.2 By Country, Global Treatment-Resistant Hypertension Management Market Size, 2019-2030

8.3 U.S.

8.3.1 U.S. Treatment-Resistant Hypertension Management Market Size, 2019-2030

8.3.2 By Company, U.S. Treatment-Resistant Hypertension Management Revenue Market Share, 2019-2024

8.3.3 By Type, U.S. Treatment-Resistant Hypertension Management Revenue Market Share, 2023 VS 2030

8.3.4 By Application, U.S. Treatment-Resistant Hypertension Management Revenue Market Share, 2023 VS 2030

8.4 Europe

8.4.1 Europe Treatment-Resistant Hypertension Management Market Size, 2019-2030

8.4.2 By Company, Europe Treatment-Resistant Hypertension Management Revenue Market Share, 2019-2024

8.4.3 By Type, Europe Treatment-Resistant Hypertension Management Revenue Market Share, 2023 VS 2030

8.4.4 By Application, Europe Treatment-Resistant Hypertension Management Revenue Market Share, 2023 VS 2030

8.5 China

8.5.1 China Treatment-Resistant Hypertension Management Market Size, 2019-2030

8.5.2 By Company, China Treatment-Resistant Hypertension Management Revenue Market Share, 2019-2024

8.5.3 By Type, China Treatment-Resistant Hypertension Management Revenue Market Share, 2023 VS 2030

8.5.4 By Application, China Treatment-Resistant Hypertension Management Revenue Market Share, 2023 VS 2030

8.6 Japan

8.6.1 Japan Treatment-Resistant Hypertension Management Market Size, 2019-2030

8.6.2 By Company, Japan Treatment-Resistant Hypertension Management Revenue Market Share, 2019-2024

8.6.3 By Type, Japan Treatment-Resistant Hypertension Management Revenue Market Share, 2023 VS 2030

8.6.4 By Application, Japan Treatment-Resistant Hypertension Management Revenue Market Share, 2023 VS 2030

8.7 South Korea

8.7.1 South Korea Treatment-Resistant Hypertension Management Market Size, 2019-2030

8.7.2 By Company, South Korea Treatment-Resistant Hypertension Management Revenue Market Share, 2019-2024

8.7.3 By Type, South Korea Treatment-Resistant Hypertension Management Revenue Market Share, 2023 VS 2030

8.7.4 By Application, South Korea Treatment-Resistant Hypertension Management Revenue Market Share, 2023 VS 2030

8.8 Southeast Asia

8.8.1 Southeast Asia Treatment-Resistant Hypertension Management Market Size, 2019-2030

8.8.2 By Company, Southeast Asia Treatment-Resistant Hypertension Management Revenue Market Share, 2019-2024

8.8.3 By Type, Southeast Asia Treatment-Resistant Hypertension Management Revenue Market Share, 2023 VS 2030

8.8.4 By Application, Southeast Asia Treatment-Resistant Hypertension Management Revenue Market Share, 2023 VS 2030

8.9 India

8.9.1 India Treatment-Resistant Hypertension Management Market Size, 2019-2030

8.9.2 By Company, India Treatment-Resistant Hypertension Management Revenue Market Share, 2019-2024

8.9.3 By Type, India Treatment-Resistant Hypertension Management Revenue Market Share, 2023 VS 2030

8.9.4 By Application, India Treatment-Resistant Hypertension Management Revenue Market Share, 2023 VS 2030

8.10 Middle East & Asia

8.10.1 Middle East & Asia Treatment-Resistant Hypertension Management Market Size, 2019-2030

8.10.2 By Company, Middle East & Asia Treatment-Resistant Hypertension Management Revenue Market Share, 2019-2024

8.10.3 By Type, Middle East & Asia Treatment-Resistant Hypertension Management Revenue Market Share, 2023 VS 2030

8.10.4 By Application, Middle East & Asia Treatment-Resistant Hypertension Management Revenue Market Share, 2023 VS 2030

9 Global Manufacturers Profile

9.1 Janssen Biotech

9.1.1 Janssen Biotech Company Information, Head Office, Market Area and Industry Position

9.1.2 Janssen Biotech Company Profile and Main Business

9.1.3 Janssen Biotech Treatment-Resistant Hypertension Management Models, Specifications and Application

9.1.4 Janssen Biotech Treatment-Resistant Hypertension Management Revenue and Gross Margin, 2019-2024

9.1.5 Janssen Biotech Recent Developments

9.2 Quantum Genomics

9.2.1 Quantum Genomics Company Information, Head Office, Market Area and Industry Position

9.2.2 Quantum Genomics Company Profile and Main Business

9.2.3 Quantum Genomics Treatment-Resistant Hypertension Management Models, Specifications and Application

9.2.4 Quantum Genomics Treatment-Resistant Hypertension Management Revenue and Gross Margin, 2019-2024

9.2.5 Quantum Genomics Recent Developments

9.3 CinCor Pharma

9.3.1 CinCor Pharma Company Information, Head Office, Market Area and Industry Position

9.3.2 CinCor Pharma Company Profile and Main Business

9.3.3 CinCor Pharma Treatment-Resistant Hypertension Management Models, Specifications and Application

9.3.4 CinCor Pharma Treatment-Resistant Hypertension Management Revenue and Gross Margin, 2019-2024

9.3.5 CinCor Pharma Recent Developments

9.4 Ionis Pharmaceuticals

9.4.1 Ionis Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

9.4.2 Ionis Pharmaceuticals Company Profile and Main Business

9.4.3 Ionis Pharmaceuticals Treatment-Resistant Hypertension Management Models, Specifications and Application

9.4.4 Ionis Pharmaceuticals Treatment-Resistant Hypertension Management Revenue and Gross Margin, 2019-2024

9.4.5 Ionis Pharmaceuticals Recent Developments

9.5 Vifor Pharma

9.5.1 Vifor Pharma Company Information, Head Office, Market Area and Industry Position

9.5.2 Vifor Pharma Company Profile and Main Business

9.5.3 Vifor Pharma Treatment-Resistant Hypertension Management Models, Specifications and Application

9.5.4 Vifor Pharma Treatment-Resistant Hypertension Management Revenue and Gross Margin, 2019-2024

9.5.5 Vifor Pharma Recent Developments

9.6 KBP Biosciences

9.6.1 KBP Biosciences Company Information, Head Office, Market Area and Industry Position

9.6.2 KBP Biosciences Company Profile and Main Business

9.6.3 KBP Biosciences Treatment-Resistant Hypertension Management Models, Specifications and Application

9.6.4 KBP Biosciences Treatment-Resistant Hypertension Management Revenue and Gross Margin, 2019-2024

9.6.5 KBP Biosciences Recent Developments

9.7 Abbott

9.7.1 Abbott Company Information, Head Office, Market Area and Industry Position

9.7.2 Abbott Company Profile and Main Business

9.7.3 Abbott Treatment-Resistant Hypertension Management Models, Specifications and Application

9.7.4 Abbott Treatment-Resistant Hypertension Management Revenue and Gross Margin, 2019-2024

9.7.5 Abbott Recent Developments

9.8 Kona Medical

9.8.1 Kona Medical Company Information, Head Office, Market Area and Industry Position

9.8.2 Kona Medical Company Profile and Main Business

9.8.3 Kona Medical Treatment-Resistant Hypertension Management Models, Specifications and Application

9.8.4 Kona Medical Treatment-Resistant Hypertension Management Revenue and Gross Margin, 2019-2024

9.8.5 Kona Medical Recent Developments

9.9 Medtronic

9.9.1 Medtronic Company Information, Head Office, Market Area and Industry Position

9.9.2 Medtronic Company Profile and Main Business

9.9.3 Medtronic Treatment-Resistant Hypertension Management Models, Specifications and Application

9.9.4 Medtronic Treatment-Resistant Hypertension Management Revenue and Gross Margin, 2019-2024

9.9.5 Medtronic Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Treatment-Resistant Hypertension Management Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
How are players chosen for the research coverage of the Treatment-Resistant Hypertension Management Market study?
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
What is the anticipated growth rate for the Treatment-Resistant Hypertension Management Market?
During the projected year from 2025 to 2030, the Treatment-Resistant Hypertension Management Market is expected to grow at a CAGR of xx%.
Where does the Treatment-Resistant Hypertension Management Industry stands in terms of scaling end-use implementations?
According to the Treatment-Resistant Hypertension Management Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.
Who should consider the Treatment-Resistant Hypertension Management Market study?
The Treatment-Resistant Hypertension Management Industry stakeholders, executives, and experts, as well as individuals who need to develop consumer-friendly strategies and use technology to stay ahead of the competition.